Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125671661 | 12567166 | 1 | I | 20160629 | 20160708 | 20160718 | 20160718 | EXP | GB-MHRA-TPP30327262C2184703YC1467207282353 | GB-MYLANLABS-2016M1028687 | MYLAN | 0.00 | Y | 0.00000 | 20160718 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125671661 | 12567166 | 1 | PS | DOXYCYCLINE. | DOXYCYCLINE | 1 | UNK | U | U | 62337 | |||||||||
| 125671661 | 12567166 | 2 | C | AMITRIPTYLINE HYDROCHLORIDE. | AMITRIPTYLINE HYDROCHLORIDE | 1 | 1 DF, QD (BEFORE BEDTIME) | 109.958 | DF | U | 0 | 1 | DF | QD | |||||
| 125671661 | 12567166 | 3 | C | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | 1 DF, UNK | 2 | DF | U | 0 | 1 | DF | ||||||
| 125671661 | 12567166 | 4 | C | DEPO-PROVERA | MEDROXYPROGESTERONE ACETATE | 1 | UNK (USE AS DIRECTED) | U | 0 | ||||||||||
| 125671661 | 12567166 | 5 | C | HYOSCINE BUTYLBROMIDE | BUTYLSCOPOLAMINE | 1 | 1 DF, TID | 593.875 | DF | U | 0 | 1 | DF | TID | |||||
| 125671661 | 12567166 | 6 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 1 DF, BID | 758 | DF | U | 0 | 1 | DF | BID | |||||
| 125671661 | 12567166 | 7 | C | LAXIDO /06401201/ | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | UNK (USE AS DIRECTED) | U | 0 | ||||||||||
| 125671661 | 12567166 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 1 DF, QD (EACH MORNING) | 484.958008 | DF | U | 0 | 1 | DF | QD | |||||
| 125671661 | 12567166 | 9 | C | MEDROXYPROGESTERONE ACETATE. | MEDROXYPROGESTERONE ACETATE | 1 | UNK (PERSONALLY ADMINISTERED) | U | 0 | ||||||||||
| 125671661 | 12567166 | 10 | C | MEFENAMIC ACID. | MEFENAMIC ACID | 1 | 1 DF, TID | 2705.875 | DF | U | 0 | 1 | DF | TID |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125671661 | 12567166 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125671661 | 12567166 | Abdominal pain upper | |
| 125671661 | 12567166 | Nausea | |
| 125671661 | 12567166 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125671661 | 12567166 | 1 | 20160629 | 0 | ||
| 125671661 | 12567166 | 2 | 20160311 | 0 | ||
| 125671661 | 12567166 | 3 | 20160629 | 0 | ||
| 125671661 | 12567166 | 4 | 20150709 | 0 | ||
| 125671661 | 12567166 | 5 | 20151214 | 0 | ||
| 125671661 | 12567166 | 6 | 20150616 | 0 | ||
| 125671661 | 12567166 | 7 | 20140109 | 0 | ||
| 125671661 | 12567166 | 8 | 20150302 | 0 | ||
| 125671661 | 12567166 | 9 | 20160527 | 20160528 | 0 | |
| 125671661 | 12567166 | 10 | 20140109 | 0 |